
    
      The study was an open label, balanced, randomized, two-treatment, two-period, two
      sequence,single dose, crossover, oral bioequivalence study of Donepezil Hydrochloride tablets
      10 mg of Dr. Reddy's Laboratories Limited, India comparing with that of ARICEPTÂ® (containing
      Donepezil Hydrochloride) tablets 10 mg of Pfizer Inc, New York, 10017 in healthy, adult,
      human subjects under fasting condition. 28 subjects are enrolled in the study, and 26
      subjects are completed the study.
    
  